Paradigm Biopharmaceuticals Ltd (PAR) - Total Liabilities

Latest as of December 2025: AU$17.16 Million AUD ≈ $12.14 Million USD

Based on the latest financial reports, Paradigm Biopharmaceuticals Ltd (PAR) has total liabilities worth AU$17.16 Million AUD (≈ $12.14 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Paradigm Biopharmaceuticals Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Paradigm Biopharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. See Paradigm Biopharmaceuticals Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Paradigm Biopharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Paradigm Biopharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Exasol AG XETRA:EXL	Germany	€14.97 Million
Granite Point Mortgage Trust Inc NYSE:GPMT	USA	$998.61 Million
Syntek Semiconductor Co Ltd TWO:5302	Taiwan	NT$548.79 Million
DRTECH Corporation KQ:214680	Korea	₩131.88 Billion
Dae Chang KO:012800	Korea	₩548.66 Billion
WI Co. Ltd. KQ:073570	Korea	₩2.15 Billion
Supercom Ltd NASDAQ:SPCB	USA	$24.87 Million
MGB Bhd KLSE:7595	Malaysia	RM525.43 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Paradigm Biopharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Paradigm Biopharmaceuticals Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Paradigm Biopharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Paradigm Biopharmaceuticals Ltd (2014–2025)

The table below shows the annual total liabilities of Paradigm Biopharmaceuticals Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$3.39 Million ≈ $2.40 Million	-5.49%
2024-06-30	AU$3.58 Million ≈ $2.54 Million	-73.23%
2023-06-30	AU$13.39 Million ≈ $9.48 Million	+59.88%
2022-06-30	AU$8.38 Million ≈ $5.93 Million	+28.49%
2021-06-30	AU$6.52 Million ≈ $4.61 Million	+55.88%
2020-06-30	AU$4.18 Million ≈ $2.96 Million	+54.62%
2019-06-30	AU$2.70 Million ≈ $1.91 Million	+103.80%
2018-06-30	AU$1.33 Million ≈ $939.01K	+38.92%
2017-06-30	AU$955.29K ≈ $675.93K	-14.45%
2016-06-30	AU$1.12 Million ≈ $790.13K	+93.42%
2015-06-30	AU$577.33K ≈ $408.49K	+56.60%
2014-06-30	AU$368.67K ≈ $260.85K	--

About Paradigm Biopharmaceuticals Ltd

AU:PAR Australia Biotechnology

Market Cap

$63.20 Million

AU$89.33 Million AUD

Market Cap Rank

#21034 Global

#717 in Australia

Share Price

AU$0.17

Change (1 day)

-5.56%

52-Week Range

AU$0.14 - AU$0.47

All Time High

AU$4.35